ClinicalTrials.Veeva

Menu

Prolactin Hormone in Oral Lichen Planus

O

October University for Modern Sciences and Arts

Status

Completed

Conditions

Oral Lichen Planus

Study type

Observational

Funder types

Other

Identifiers

NCT04785703
REC18-048

Details and patient eligibility

About

Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with oral lichen planus
  • systemically healthy

Exclusion criteria

  • oral lichenoid lesions

Trial design

40 participants in 1 patient group

oral lichen planus group
Description:
patients with chronic bollus erosive lichen planus

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems